Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (288)	5/5/1998 12:07:00 PM
From: HB	Read Replies (2) \| Respond to of 717

The PCYC buying yesterday seemed to come in two surges, one at the open and one in the afternoon (unfortunately, I forgot the exact time). Can anyone correlate these with market events, like announcements by other companies, like the ENMD thing. Seems like maybe WLA's buyout of gene/Network, Elan's buyout of Neurex, may be sparking more interest in biotech. Don't know if that's moving PCYC, though. If they don't correlate with anything particular, it could represent semi-insiders buying with foreknowledge or guesses about announcments to come. Cheers, HB